The Case for Disclosing Biomarker Results to Alzheimer’s Research Participants
Though several validated biomarkers are studied and used in Alzheimer’s disease research, most research participants don’t have the opportunity to learn their biomarker results afterward, even if they...
15 Nov 202239min
Promoting Open Science and Community Engagement with the National Institute on Aging
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 6 Concluding our special series on the 2022 Spring ADRC Meeting, Dr. Cerise Elliott joins the podc...
1 Nov 202210min
Moving into the Digital Era of Alzheimer’s Disease Research
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 5 Whether it be due to new research findings, innovative approaches and ideas, or technological ad...
25 Okt 202218min
National Efforts to Standardize Brain Scan Data for More Accurate Alzheimer’s Risk Predictions
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 4 Brain imaging is a key tool in Alzheimer’s disease research and diagnoses, allowing scientists t...
18 Okt 202215min
Protecting Participant Privacy and Making Predictions Using Alzheimer’s Data
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 3 With big data comes big responsibility. Dr. Sean Mooney joins the podcast to discuss his work wi...
11 Okt 202218min
The Future of Sharing and Accessing Alzheimer’s Disease Data
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 2 Dr. Sarah Biber, the program director for NACC, joins the podcast to discuss building a one-stop...
4 Okt 202214min
Introducing the National Alzheimer’s Coordinating Center
Dementia Matters Special Series: The National Strategy for Alzheimer's Disease Data and Research Part 1: Kicking off our six-episode series on the National Alzheimer’s Coordinating Center and their Sp...
27 Sep 202222min
Study Shows APOE e4 Not Associated with Alzheimer’s Disease in American Indian Populations
Researchers typically recognize the APOE e4 gene as a significant genetic risk factor for cognitive decline and dementia. However, a new study has found that the allele is not linked to neurodegenerat...
13 Sep 202226min
